Latest News
ARS Pharmaceuticals, Inc.
- ARS Pharmaceuticals, Inc. Estimates – BOATS:SPRY
- Form 144 ARS PHARMACEUTICALS For: 20 October By Investing.com
- ARS Pharmaceuticals (NasdaqGM:SPRY) Stock Forecast & Analyst Predictions
- Form 4 ARS Pharmaceuticals Inc For: 12 October By Investing.com
- SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit with SBS Law
- Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 5, 2026 in ARS Pharmaceuticals Inc. Lawsuit - SPRY
- SPRY FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds ARS Pharmaceuticals Investors of Securities Class Action Lawsuit Deadline on October 5, 2026
- ARS PHARMACEUTICALS DEADLINE MONDAY: Bragar Eagel & Squire,
- ARS Pharmaceuticals Deadline: SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit
- Bragar Eagel & Squire, P.C. Reminds ARS Pharmaceuticals
- SPRY Shareholder Alert: October 5, 2026 Lead Plaintiff Deadline in ARS Pharmaceuticals Inc. Securities Class Action - Contact SueWallSt
- Bronstein, Gewirtz & Grossman LLC Urges ARS Pharmaceuticals
Headlines from the last 30 days, linking to the original publishers. See all market news →